Longitudinal associations between patient and caregiver quality of life following hematopoietic stem cell transplantation.

12087 Background: Caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT) experience high rates of psychological distress, yet patient-level factors most strongly associated with caregiver outcomes over time remain poorly understood. We evaluated longitudinal associations between patient and caregiver quality of life (QoL) following HSCT. Methods: We conducted a secondary analysis of the PROTECT randomized trial of integrated palliative care during HSCT. Among enrolled patient-caregiver dyads, we measured patient (FACT-BMT) and caregiver (CarGOQoL) QoL at baseline, week 2, and months 3, 6, and 12. Only patient-caregiver dyads that completed both measures were included in analyses at each timepoint. Linear mixed-effects models were used to assess the relationship between changes in patient QoL and changes in caregiver QoL, adjusting for time and treatment arm. Results: Among 186 enrolled patient-caregiver dyads, patients had a mean age of 55.2 ± 12.4 years and 65% were male. Mean CarGOQoL remained stable from baseline through month 12 (range: 74.1–75.9). FACT-BMT declined at week 2 (91.9 ± 20.4) compared to baseline (105.0 ± 18.8), then recovered and improved by month 3 through month 12 (Table 1). In multivariable mixed-effects modeling, within dyads, visits where the patient’s QoL exceeded their usual level were associated with higher caregiver QoL (β = 0.11 per 1-point above the patient’s mean; p < 0.001), adjusted for time and arm. Conclusions: While average caregiver QoL remained stable throughout the follow-up period despite changes in average patient QoL, individual caregiver QoL closely tracked their patient's QoL over the post-HSCT follow-up period. Patient-reported QoL represents a clinically meaningful marker to identify at-risk caregivers. Interventions targeting patient QoL may yield dual benefits for patient-caregiver dyads. Clinical trial information: NCT03641378 . Patient and caregiver quality of life by timepoint. Outcome Baseline (n = 183) Week 2 (n = 157) Month 3 (n = 126) Month 6 (n = 112) Month 12 (n = 109) Patient FACT-BMT (mean +/- SD) 105.0 +/- 18.8 91.9 +/- 20.4 107.0 +/- 18.4 111.0 +/- 19.6 112.0 +/- 19.9 Caregiver CarGOQoL (mean +/- SD) 74.1 +/- 12.0 74.1 +/- 12.7 75.9 +/- 12.8 75.8 +/- 13.8 75.7 +/- 14.8 Spearman 0.37 (p < 0.001) 0.27 (p < 0.001) 0.25 (p = 0.004) 0.40 (p < 0.001) 0.38 (p < 0.001)

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-27
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.12087
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal associations between patient and caregiver quality of life following hematopoietic stem cell transplantation.

Jesse D. Troy, Brenda Branchaud, Kris W. Herring, Thomas William LeBlanc et al.
Journal of Clinical Oncology
Cancer survivorship and care
article

Longitudinal associations between patient and caregiver quality of life following hematopoietic stem cell transplantation.

Jesse D. Troy, Brenda Branchaud, Kris W. Herring, Thomas William LeBlanc, Areej El-Jawahri, Daniel Yang
article en

Abstract

12087 Background: Caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT) experience high rates of psychological distress, yet patient-level factors most strongly associated with caregiver outcomes over time remain poorly understood. We evaluated longitudinal associations between patient and caregiver quality of life (QoL) following HSCT. Methods: We conducted a secondary analysis of the PROTECT randomized trial of integrated palliative care during HSCT. Among enrolled patient-caregiver dyads, we measured patient (FACT-BMT) and caregiver (CarGOQoL) QoL at baseline, week 2, and months 3, 6, and 12. Only patient-caregiver dyads that completed both measures were included in analyses at each timepoint. Linear mixed-effects models were used to assess the relationship between changes in patient QoL and changes in caregiver QoL, adjusting for time and treatment arm. Results: Among 186 enrolled patient-caregiver dyads, patients had a mean age of 55.2 ± 12.4 years and 65% were male. Mean CarGOQoL remained stable from baseline through month 12 (range: 74.1–75.9). FACT-BMT declined at week 2 (91.9 ± 20.4) compared to baseline (105.0 ± 18.8), then recovered and improved by month 3 through month 12 (Table 1). In multivariable mixed-effects modeling, within dyads, visits where the patient’s QoL exceeded their usual level were associated with higher caregiver QoL (β = 0.11 per 1-point above the patient’s mean; p < 0.001), adjusted for time and arm. Conclusions: While average caregiver QoL remained stable throughout the follow-up period despite changes in average patient QoL, individual caregiver QoL closely tracked their patient's QoL over the post-HSCT follow-up period. Patient-reported QoL represents a clinically meaningful marker to identify at-risk caregivers. Interventions targeting patient QoL may yield dual benefits for patient-caregiver dyads. Clinical trial information: NCT03641378 . Patient and caregiver quality of life by timepoint. Outcome Baseline (n = 183) Week 2 (n = 157) Month 3 (n = 126) Month 6 (n = 112) Month 12 (n = 109) Patient FACT-BMT (mean +/- SD) 105.0 +/- 18.8 91.9 +/- 20.4 107.0 +/- 18.4 111.0 +/- 19.6 112.0 +/- 19.9 Caregiver CarGOQoL (mean +/- SD) 74.1 +/- 12.0 74.1 +/- 12.7 75.9 +/- 12.8 75.8 +/- 13.8 75.7 +/- 14.8 Spearman 0.37 (p < 0.001) 0.27 (p < 0.001) 0.25 (p = 0.004) 0.40 (p < 0.001) 0.38 (p < 0.001)

Journal of Clinical OncologyVol. 44(16_suppl)
Harvard University (US), Duke University (US), Massachusetts General Hospital (US), Duke Medical Center (US), Duke Cancer Institute
Openalex Percentile: Top 10%
Cancer survivorship and care
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.